PODD
INSULET CORP
NASDAQ · Healthcare · Medical - Devices · US
$140.60
−0.67%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.59
- Revenue estimate
- $840.9M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $1.66
- EPS estimate
- $1.48
- Revenue actual
- $801.7M
- Revenue estimate
- $794.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +9.3%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $165
- PT range
- $144 – $190
- Analysts
- 15
7 Buy8 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $1.48 | $1.66 | Beat 12.54% | $801.7M |
| May 6, 2026 | $1.20 | $1.42 | Beat 18.73% | $761.7M |
| Feb 18, 2026 | $1.48 | $1.44 | Miss -2.70% | $783.8M |
| Nov 6, 2025 | $1.14 | $1.24 | Beat 8.77% | $706.3M |
| Aug 7, 2025 | $0.92 | $1.17 | Beat 27.17% | $649.1M |
| May 8, 2025 | $0.79 | $1.02 | Beat 29.11% | $569.0M |
| Feb 20, 2025 | $1.00 | $1.15 | Beat 15.00% | $597.5M |
| Nov 7, 2024 | $0.76 | $0.90 | Beat 18.42% | $372.6M |
| Aug 8, 2024 | $0.56 | $0.55 | Miss -2.48% | $488.5M |
| May 9, 2024 | $0.39 | $0.73 | Beat 87.18% | $441.7M |
| Feb 22, 2024 | $0.66 | $1.40 | Beat 112.12% | $509.8M |
| Nov 2, 2023 | $0.40 | $0.71 | Beat 77.50% | $432.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026